SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-02-08 09:52
Tx date 2024-02-05 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+70,000 vol 		477,658
Filed 2023-08-11 11:02
Tx date 2023-05-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-5,707,305 vol 		407,658
Filed 2023-08-11 10:58
Tx date 2023-05-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-479,036 vol 		34,216
Filed 2023-01-24 15:30
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+150,000 vol 		513,252
Filed 2023-01-24 15:29
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-150,000 vol 		0
Filed 2023-01-24 15:28
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+150,000 vol 		150,000
Filed 2023-01-24 15:28
Tx date 2023-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+400,000 vol 		6,114,963
Filed 2022-09-22 09:53
Tx date 2022-09-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,939
+4,300 vol
$0.68 each 		363,252
Filed 2022-09-22 09:52
Tx date 2022-09-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,895
+5,700 vol
$0.68 each 		358,952
Filed 2022-07-08 14:52
Tx date 2022-07-06 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+600,000 vol 		5,714,963
Filed 2022-06-07 15:18
Tx date 2022-06-06 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,709
+1,762 vol
$0.97 each 		353,252
Filed 2022-06-07 15:17
Tx date 2022-06-06 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,940
+4,062 vol
$0.97 each 		351,490
Filed 2022-06-07 15:16
Tx date 2022-06-06 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,351
+1,400 vol
$0.97 each 		347,428
Filed 2022-06-07 15:16
Tx date 2022-06-06 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,679
+2,776 vol
$0.97 each 		346,028
Filed 2022-01-20 18:52
Tx date 2022-01-18 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+700,000 vol 		5,114,963
Filed 2021-12-17 17:45
Tx date 2021-12-16 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,830
+2,520 vol
$1.52 each 		343,252
Filed 2021-12-17 17:44
Tx date 2021-12-16 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,794
+2,480 vol
$1.53 each 		340,732
Filed 2021-12-17 17:44
Tx date 2021-12-16 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,599
+5,000 vol
$1.52 each 		338,252
Filed 2021-12-17 17:43
Tx date 2021-12-16 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,774
+3,183 vol
$1.50 each 		333,252
Filed 2021-12-15 15:59
Tx date 2021-12-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,964
+1,754 vol
$1.12 each 		330,069
Filed 2021-12-15 15:59
Tx date 2021-12-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,549
+5,000 vol
$1.11 each 		328,315
Filed 2021-12-15 15:58
Tx date 2021-12-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,684
+3,246 vol
$1.14 each 		323,315
Filed 2021-12-15 15:58
Tx date 2021-12-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,641
+5,000 vol
$1.13 each 		320,069
Filed 2021-12-15 15:57
Tx date 2021-12-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,160
+2,822 vol
$1.12 each 		315,069
Filed 2021-11-29 16:06
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$325.32
+143 vol
$2.27 each 		312,247
Filed 2021-11-29 16:06
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,136
+500 vol
$2.27 each 		312,104
Filed 2021-11-29 16:05
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,147
+500 vol
$2.29 each 		311,604
Filed 2021-11-29 16:04
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,149
+500 vol
$2.30 each 		311,104
Filed 2021-11-29 16:03
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$924.00
+400 vol
$2.31 each 		310,604
Filed 2021-11-29 16:02
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,385
+600 vol
$2.31 each 		310,204
Filed 2021-11-29 16:01
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,319
+1,000 vol
$2.32 each 		309,604
Filed 2021-11-29 15:59
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,319
+1,000 vol
$2.32 each 		308,604
Filed 2021-11-29 15:59
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,637
+2,000 vol
$2.32 each 		307,604
Filed 2021-11-29 15:55
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,328
+1,000 vol
$2.33 each 		305,604
Filed 2021-11-29 15:52
Tx date 2021-11-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,325
+1,000 vol
$2.33 each 		304,604
Filed 2021-07-06 17:34
Tx date 2021-07-02 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,277
+1,000 vol
$3.28 each 		303,604
Filed 2021-07-06 17:33
Tx date 2021-07-02 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,285
+1,000 vol
$3.29 each 		302,604
Filed 2021-07-06 17:32
Tx date 2021-07-02 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,556
+1,081 vol
$3.29 each 		301,604
Filed 2021-07-06 17:31
Tx date 2021-07-02 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,590
+2,000 vol
$3.29 each 		300,523
Filed 2021-07-06 17:30
Tx date 2021-07-02 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,280
+1,000 vol
$3.28 each 		298,523
Filed 2021-03-12 18:25
Tx date 2021-03-08 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$102,000
+30,000 vol
$3.40 each 		35,263
Filed 2021-01-06 20:12
Tx date 2021-01-04 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+343,000 vol 		4,414,963
Filed 2020-12-02 15:59
Tx date 2020-12-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,971 vol 		63,761
Filed 2020-12-02 15:58
Tx date 2020-12-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-3,971 vol 		8,134
Filed 2020-10-05 19:45
Tx date 2020-10-05 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+11,010 vol 		59,790
Filed 2020-10-05 19:44
Tx date 2020-10-05 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-17,483 vol 		12,105
Filed 2020-10-05 19:43
Tx date 2020-10-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+17,483 vol 		29,588
Filed 2020-07-10 19:37
Tx date 2020-07-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,021,790.55
-168,891 vol
$6.05 each 		297,523
Filed 2020-07-10 19:35
Tx date 2020-07-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+300,000 vol 		466,414
Filed 2020-07-10 19:34
Tx date 2020-07-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-300,000 vol 		0
Filed 2020-03-26 16:20
Tx date 2020-03-25 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$19,802
+3,400 vol
$5.82 each 		166,414
Filed 2020-03-14 14:00
Tx date 2020-03-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+300,000 vol 		300,000
Filed 2020-02-03 10:56
Tx date 2020-01-31 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+2,000,000 vol 		4,071,963
Filed 2020-01-17 10:50
Tx date 2020-01-16 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+10,526 vol 		48,780
Filed 2020-01-17 10:47
Tx date 2020-01-16 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-10,526 vol 		12,105
Filed 2019-10-28 11:39
Tx date 2019-10-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$19,200
+10,000 vol
$1.92 each 		163,014
Filed 2019-10-08 09:49
Tx date 2019-10-03 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-8,377 vol 		22,631
Filed 2019-10-08 09:45
Tx date 2019-10-03 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+5,182 vol 		38,254
Filed 2019-10-08 09:44
Tx date 2019-10-08 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-8,377 vol
Filed 2019-10-04 10:43
Tx date 2019-10-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+27,809 vol 		33,072
Filed 2019-10-04 10:39
Tx date 2019-10-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-44,827 vol 		31,008
Filed 2019-10-04 10:38
Tx date 2019-10-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+44,827 vol 		75,835
Filed 2019-04-22 09:05
Tx date 2019-04-18 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,507
+10,000 vol
$1.85 each 		153,014
Filed 2019-03-17
Tx date 2019-03-14 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,993
+10,000 vol
$1.90 each 		143,014
Filed 2019-01-03
Tx date 2019-01-02 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+400,000 vol 		2,071,963
Filed 2018-11-30
Tx date 2018-11-28 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+5,263 vol 		5,263
Filed 2018-11-30
Tx date 2015-06-08 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-30
Tx date 2018-05-22 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-44,737 vol 		5,263
Filed 2018-11-30
Tx date 2018-11-28 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-5,263 vol 		31,008
Filed 2018-11-30
Tx date 2018-11-27 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+8,134 vol 		36,271
Filed 2018-11-30
Tx date 2018-05-22 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation
-239,178 vol 		28,137
Filed 2018-10-17
Tx date 2018-10-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+50,000 vol 		133,014
Filed 2018-10-17
Tx date 2018-10-15 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-50,000 vol 		0
Filed 2018-10-09
Tx date 2018-10-08 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$21,250
+10,000 vol
$2.13 each 		83,014
Filed 2018-07-16
Tx date 2018-07-13 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+50,000 vol 		50,000
Filed 2018-07-16
Tx date 2018-07-16 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$31,100
+10,000 vol
$3.11 each 		73,014
Filed 2018-01-23
Tx date 2018-01-22 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+400,000 vol 		1,671,963
Filed 2018-01-23
Tx date 2018-01-19 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+300,000 vol 		1,271,963
Filed 2017-12-04
Tx date 2017-12-01 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+37,729 vol 		267,315
Filed 2017-06-30
Tx date 2017-06-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-50,000 vol 		0
Filed 2017-06-30
Tx date 2017-06-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-22,783.20
-18,986 vol
$1.20 each 		63,014
Filed 2017-06-30
Tx date 2017-06-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+50,000 vol 		82,000
Filed 2017-06-30
Tx date 2017-06-26 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$22,799
+20,000 vol
$1.14 each 		32,000
Filed 2017-06-09
Tx date 2017-06-06 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$51,500
+50,000 vol
$1.03 each 		971,963
Filed 2017-03-31
Tx date 2017-03-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+50,000 vol 		50,000
Filed 2017-03-31
Tx date 2013-10-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31
Tx date 2017-03-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		921,963
Filed 2017-01-19
Tx date 2017-01-16 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+100,000 vol 		229,586
Filed 2016-10-06
Tx date 2016-10-03 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+79,586 vol 		129,586
Filed 2016-04-04
Tx date 2016-03-31 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$229,200
+60,000 vol
$3.82 each 		821,963
Filed 2015-12-14
Tx date 2015-12-09 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights 		$20,000
+50,000 vol
$0.40 each 		50,000
Filed 2015-12-14
Tx date 2015-06-08 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-02
Tx date 2015-11-30 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,000
+4,000 vol
$3.00 each 		12,000
Filed 2015-11-27
Tx date 2015-11-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$310.00
+100 vol
$3.10 each 		8,000
Filed 2015-11-27
Tx date 2015-11-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,480
+3,900 vol
$3.20 each 		7,900
Filed 2015-11-27
Tx date 2015-11-24 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,480
+3,900 vol
$3.20 each
Filed 2015-06-18
Tx date 2015-06-08 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$40,000
+50,000 vol
$0.80 each 		50,000
Filed 2015-06-18
Tx date 2015-06-08 		$ONC
Oncolytics Biotech Inc. 		Rice, William Glenn
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-11
Tx date 2015-06-10 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$835,200
+120,000 vol
$6.96 each 		761,963
Filed 2015-05-12
Tx date 2014-10-01 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-7,061,587 vol 		641,963
Filed 2015-05-12
Tx date 2015-05-11 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,534
+1,100 vol
$5.94 each 		4,000
Filed 2015-05-12
Tx date 2015-05-11 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,391
+900 vol
$5.99 each 		2,900
Filed 2015-05-12
Tx date 2015-05-08 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,040
+1,000 vol
$6.04 each 		2,000
Filed 2015-05-12
Tx date 2015-05-08 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,090
+1,000 vol
$6.09 each 		1,000
Filed 2015-05-12
Tx date 2015-05-08 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$60,900
+10,000 vol
$6.09 each
Filed 2015-05-12
Tx date 2015-05-08 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$60,900
+10,000 vol
$6.09 each
Filed 2015-05-12
Tx date 2013-10-28 		$APS
Aptose Biosciences Inc. 		Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report